Are you using real-world evidence?

Parexel’s experts offer a roadmap and best practices for current RWE applications across three development arenas:

  • Early asset planning
  • Clinical development: Meeting regulatory expectations
  • Medical marketplace: Demonstrating value in the real world

In each section of this playbook, we highlight examples of recent Parexel projects that illustrate the power of RWE to improve decision-making and to drive cost- and times-saving development strategies.


Open PDF

Return to Insights Center

Related Insights

Webinar

Use of AI to develop health economic evidence for optimized patient access

Sep 6, 2023

Blog

Accelerating Delivery and Patient Access to Rare Disease Treatments – Highlights from World Orphan Drug Congress

May 2, 2024

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Whitepaper

Addressing the Challenges of Artificial Intelligence used for Data Extraction in Systematic Literature Reviews

Mar 15, 2023

Whitepaper

The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations

Mar 9, 2023

Blog

Using ethical AI to streamline HEOR

Jan 26, 2024

Article

Near-term strategies for biotech drug developers facing shifting healthcare dynamics

Feb 14, 2024

Blog

Regulatory acceptability of AI: Current perspectives

Mar 7, 2024

Blog

Summary and assessment of EMA’s reflection paper on the use of artificial intelligence (AI) in the medicinal product lifecycle

Mar 7, 2024

Blog

Summary and assessment: Using Artificial Intelligence & Machine Learning in the Development of Drug & Biological Products: Discussion Paper and Request for Feedback (FDA)

Mar 7, 2024

Related Insights

Webinar

Use of AI to develop health economic evidence for optimized patient access

Sep 6, 2023

Blog

Accelerating Delivery and Patient Access to Rare Disease Treatments – Highlights from World Orphan Drug Congress

May 2, 2024

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Whitepaper

Addressing the Challenges of Artificial Intelligence used for Data Extraction in Systematic Literature Reviews

Mar 15, 2023

Show more